novel
seri
synthes
via
cycloaddit
nmethylc
diethoxyphosphoryl
nitron
nsubstitut
naphthalimid
acrylamid
nallylnaphthalimid
cisand
transisoxazolidin
phosphon
obtain
herein
assess
antivir
activ
broad
rang
dna
rna
virus
isoxazolidin
exhibit
highest
activ
ec
lm
toward
cytomegaloviru
compound
cisand
well
cisand
found
potent
hsv
vaccinia
virus
ec
lm
rang
wherea
isoxazolidin
suppress
replic
coxsacki
punta
toro
virus
ec
lm
rang
antiprolif
evalu
obtain
isoxazolidin
reveal
promis
activ
toward
test
cancer
cell
line
ic
lm
rang
despit
signific
achiev
cancer
chemotherapi
search
select
compound
capabl
better
differenti
malign
tumor
normal
cell
abl
minim
side
effect
current
drug
continu
take
account
mechan
action
therapeut
agent
belong
differ
pharmacolog
class
among
interact
dna
dna
alkyl
agent
intercal
groov
binder
special
interest
intercal
constitut
well
explor
class
compound
mode
action
predict
reli
inhibit
replic
process
revers
bind
dna
planar
aromat
fragment
intercal
insert
dna
doubl
helix
therebi
distort
dna
backbon
conform
poison
dna
topoisomeras
ii
sever
factor
respons
stabil
drugdna
complex
name
stack
pbond
interact
van
der
waal
forc
eventu
hydrogen
bond
aromat
fragment
drug
moieti
purinepyrimidin
base
present
dna
strain
intercal
classifi
accord
aromaticheteroaromat
subunit
electrostat
potenti
poss
among
naphthalimid
deriv
found
promis
anticanc
agent
sinc
abl
intercal
dna
includ
amonafid
mitonafid
reach
clinic
trial
treatment
solid
tumor
howev
show
poor
therapeut
indic
hand
variou
function
group
present
structur
intercal
may
also
contribut
bind
drug
dna
amino
group
sugar
residu
doxorubicin
form
ionic
bond
phosphat
function
dna
result
addit
effici
stabil
lock
drug
activ
site
also
known
group
intercal
activ
relat
specif
shape
molecul
rather
aromat
ring
system
studi
intercal
properti
arylmethyl
amino
amap
prove
amino
side
chain
respons
dna
bind
due
electrostat
interact
enhanc
activ
observ
deriv
moieti
fig
compound
fig
design
new
isoxazolidinecontain
intercal
equip
planar
polycycl
aromat
framework
cytotox
apoptot
properti
alreadi
describ
recent
succeed
prepar
compound
substitu
isoxazolidin
ring
prove
cytotox
hela
cell
line
ic
valu
lm
respect
moreov
isoxazolidin
contain
carbamoyl
linker
separ
isoxazolidin
ring
substitut
phenyl
suppress
divis
three
cancer
cell
line
concentr
rang
lm
http
elsevi
ltd
right
reserv
herein
new
seri
substitut
dialkoxyphosphoryl
function
design
continu
ongo
project
direct
toward
construct
compound
antineoplast
activ
base
applic
phosphoryl
nitron
scheme
idea
behind
design
compound
base
combin
two
biolog
activ
moietiespharmacophor
name
naphthalimid
isoxazolidin
unit
intent
obtain
activ
hybrid
conjug
drug
recent
similar
approach
success
appli
sever
research
group
result
synthes
variou
seri
amonafidecontain
chimera
includ
naphthalimid
conjug
carbazol
benzodiazepin
benzoic
acid
aliphat
diamin
chain
well
peptid
nucleic
acid
approach
synthesi
phosphonyl
intercal
reli
assumpt
design
molecul
contain
aromat
system
abl
intercal
dna
diethoxyphosphoryl
function
isoxazolidin
ring
could
phosphoryl
also
contain
nonhydrolys
cp
bond
best
knowledg
acrylamid
well
allyl
naphthalimid
except
describ
literatur
purpos
studi
nsubstitut
acrylamid
synthes
start
commerci
avail
naphthal
anhydrid
via
multistep
procedur
includ
nitrat
follow
standard
reduct
nitro
group
transform
aminoanhydrid
naphthalimid
treatment
alkyl
amin
ethylenediamin
final
prepar
acrylamid
acryloyl
chlorid
presenc
triethylamin
scheme
seri
dipolarophil
obtain
reaction
naphthal
anhydrid
allylamin
furthermor
naphthalimid
convert
acetyl
deriv
cycloaddit
nitron
naphthalimid
perform
toluen
toluenechloroform
mixtur
led
format
diastereoisomer
mixtur
isoxazolidin
scheme
tabl
case
moder
transci
diastereoselect
observ
transisom
predomin
de
purif
crude
mixtur
cycloadduct
silica
gel
column
result
separ
major
diastereoisom
well
minor
isom
reaction
nitron
nallyl
naphthalimid
carri
toluen
toluenechloroform
solut
gave
mixtur
isomer
isoxazolidin
good
transci
diastereoselect
de
crude
mixtur
cycloadduct
subject
purif
silica
gel
column
subsequ
crystal
howev
attempt
separ
diastereoisom
fail
lead
mixtur
enrich
isom
scheme
tabl
rel
configur
isoxazolidin
determin
take
advantag
previou
studi
stereochemistri
cycloaddit
nmethylcdiethoxyphosphorylnitron
hetero
arylacrylamid
sinc
similar
h
nmr
spectral
pattern
respect
seri
isoxazolidin
observ
compar
previous
describ
transand
hetero
briefli
major
transisom
e
conform
fig
isoxazolidin
ring
establish
take
advantag
diagnost
valu
vicin
coupl
constant
j
cccp
hz
j
hz
j
hz
j
hz
j
hz
j
hz
j
hz
extract
respect
h
c
nmr
spectra
conform
diethoxyphosphoryl
group
resid
equatori
posit
isoxazolidin
ring
carbamoyl
substitu
locat
pseudoequatori
similarli
rel
configur
isoxazolidin
establish
base
close
stereochem
outcom
found
reaction
nitron
nallyl
naphthalimid
compar
alreadi
elabor
analog
reaction
nitron
nallyl
nucleobas
pure
insepar
mixtur
reaction
condit
toluen
toluenechloroform
yield
pure
mixtur
cisand
transisom
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopathogen
virus
compound
seri
isoxazolidin
found
activ
human
cytomegaloviru
activ
lm
tabl
among
ec
lm
ec
lm
exhibit
highest
activ
ec
valu
compar
found
refer
compound
ganciclovir
also
approv
drug
hmcv
approxim
order
magnitud
lower
assay
cidofovir
use
second
refer
howev
newgener
drug
letermovir
show
ec
lm
hcmv
strain
recent
reach
phase
iib
clinic
trial
among
seri
isoxazolidin
major
deriv
abl
inhibit
replic
tk
tk
vzv
strain
ec
valu
rang
lm
tabl
potenc
tk
vzv
strain
activ
ec
lm
found
order
three
order
magnitud
lower
refer
acyclovir
also
approv
drug
brivudin
respect
howev
activ
isoxazolidin
studi
except
tk
vzv
strain
compar
favor
ec
lm
refer
acyclovir
ec
lm
order
magnitud
less
activ
second
refer
brivudin
ec
lm
hand
none
compound
seri
found
activ
either
toward
hcmv
vzv
although
isoxazolidin
deriv
equip
n
ndimethylaminoethyl
ethyl
function
found
slightli
activ
three
strain
herp
simplex
viru
ec
valu
rang
lm
tabl
tabl
respect
moreov
compound
cytotox
toward
hel
cell
virus
replic
concentr
lm
display
minimum
cytotox
concentr
mcc
lm
second
seri
isoxazolidin
phosphon
inhibit
replic
coxsacki
viru
concentr
lm
significantli
better
ribavirin
tabl
hand
show
weak
activ
punta
toro
viru
ec
lm
higher
ribavirin
tabl
compound
alter
morpholog
vero
cell
antivir
assay
perform
sinc
drug
coxacki
punta
toro
virus
approv
far
urgenc
search
activ
compound
justifi
none
isoxazolidin
phosphon
show
activ
test
virus
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
murin
leukemia
human
lymphocyt
cem
human
cervix
carcinoma
hela
cell
synthes
compound
show
differ
antiprolif
activ
ic
rang
lm
tabl
among
isoxazolidin
carbamoyl
linker
structureact
relationship
studi
indic
presenc
tertiari
nitrogen
atom
side
chain
significantli
increas
cytostat
activ
test
compound
phosphon
straight
aliphat
chain
consider
less
cytostat
ic
lm
contain
tertiari
amino
function
name
moreov
compound
decreas
viabil
mdck
cell
line
concentr
lm
cc
respect
furthermor
transand
cisisoxazolidin
aminoalkyl
substitu
appear
cytostat
toward
cem
hela
cell
line
ic
lm
among
consid
amonafid
analogu
well
prove
highli
cytostat
toward
murin
leukemia
human
cervix
carcinoma
hela
cell
ic
lm
potenc
order
magnitud
lower
refer
besid
high
cytostat
activ
compound
found
reduc
viabil
mdck
crfk
cell
concentr
rang
lm
cc
addit
phosphon
exhibit
high
cytostat
activ
human
lymphocyt
cell
cem
compar
even
fivefold
activ
furthermor
although
correl
configur
isoxazolidin
biolog
activ
observ
transconfigur
isoxazolidin
found
twofold
cytostat
correspond
cisisom
second
seri
also
show
consider
cytostat
activ
three
test
cancer
cell
line
ic
two
new
seri
obtain
nmethylc
diethoxyphosphoryl
nitron
respect
nsubstitut
naphthalimid
acrylamid
nallyl
naphthalimid
via
cycloaddit
synthes
isoxazolidin
phosphon
well
respect
mixtur
evalu
varieti
dna
rna
virus
sever
deriv
show
activ
varicellazost
viru
cytomegaloviru
among
test
compound
isoxazolidin
exhibit
highest
activ
ec
lm
toward
cytomegaloviru
compar
activ
ganciclovir
approv
drug
use
refer
compound
isoxazolidin
except
appear
activ
tk
vzv
strain
potenc
compound
ec
lm
compar
favor
refer
acyclovir
ec
lm
also
approv
drug
test
compound
also
endow
antivir
activ
hsv
vaccinia
cisand
cisand
ec
lm
rang
coxsacki
punta
toro
ec
lm
rang
virus
although
coxsacki
viru
compound
even
activ
ribavirin
use
refer
compound
potenc
larg
enough
deserv
studi
cytostat
activ
evalu
cem
hela
cell
line
cytostat
compound
ic
valu
found
lm
rang
gener
compound
carbamoyl
linker
activ
methylen
bridg
h
nmr
spectra
taken
cdcl
follow
spectromet
varian
bruker
avanc
iii
mhz
tm
intern
standard
de
acetamid
n
mmol
treat
acet
anhydrid
ml
mmol
stir
h
room
temperatur
reaction
mixtur
cool
room
temperatur
cold
water
ml
ad
yellow
precipit
filter
wash
sever
time
water
dri
afford
naphthalimid
solut
appropri
mmol
dichloromethan
ml
triethylamin
mmol
ad
mixtur
cool
ice
bath
acryloyl
chlorid
mmol
ad
dropwis
reaction
mixtur
stir
h
room
temperatur
extract
water
ml
subsequ
inorgan
layer
extract
ethyl
ether
ml
combin
organ
layer
dri
anhydr
mgso
filter
evapor
solvent
residu
purifi
silica
column
chloroformmethanol
mixtur
vv
afford
respect
acrylamid
mixtur
nitron
mmol
acrylamid
mmol
toluen
toluenechloroform
mixtur
ml
vv
stir
h
disappear
start
nitron
evapor
solvent
reduc
pressur
crude
product
purifi
silica
gel
chromatographi
chloroformmethanol
mixtur
antivir
assay
hiv
base
inhibit
virusinduc
cytopath
plaqu
format
human
embryon
lung
hel
fibroblast
african
green
monkey
kidney
cell
vero
human
epitheli
cervix
carcinoma
cell
hela
crandellre
felin
kidney
cell
crfk
madin
darbi
canin
kidney
cell
mdck
confluent
cell
cultur
microtit
plate
inocul
ccid
viru
ccid
viru
dose
infect
cell
cultur
plaqu
form
unit
pfu
cell
cultur
incub
presenc
vari
concentr
test
compound
viral
cytopath
plaqu
format
vzv
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopath
viral
plaqu
format
cytotox
measur
base
inhibit
cell
growth
hel
cell
seed
rate
cellswel
microtit
plate
allow
adher
prolifer
h
medium
contain
differ
concentr
test
compound
ad
day
incub
cell
number
determin
coulter
counter
cytostat
concentr
calcul
cc
compound
concentr
requir
reduc
cell
prolifer
rel
number
cell
untreat
control
cc
valu
estim
graphic
plot
number
cell
percentag
control
function
concentr
test
compound
altern
cytotox
test
compound
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
cell
morpholog
